Effective Communication of Clinical Studies for Maximum Impact

CHAPEL HILL, N.C., June 17, 2008 /PRNewswire/ -- Coordinating and timing activities is a top challenge that many pharmaceutical companies face when communicating the results of landmark clinical trials. Best-in-class companies understand that successfully communicating results of a landmark trial begins long before significant findings are available. Successful communication depends on early actions across the board:

    -- Early identification of breakthrough molecules in development

    -- Early creation of potential product positioning

    -- Early involvement of marketing to build commercial endpoints into the

       study design

    -- Early scenario planning for different study results


Best Practices, LLC has benchmarked the efforts of world-class pharmaceutical companies in the development and execution of strategies for communicating clinical trial results.

For more information, download Best Practices, LLC's white paper on Communicating Clinical Study Results for Maximum Impact by clicking on the following link www.best-in-class.com/cr220.htm or contact Cameron Tew, Sr. Manager Research and Publishing at (919) 403-0251, ext. 246 or . ctew@best-in-class.com

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a research and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information, call (919) 403-0251 or visit www.best-in-class.com .

CONTACT: Kim Hardin of Best Practices, LLC, +1-919-767-9221, khardin@best-in-class.com

Web site: http://www.best-in-class.com/http://www.best-in-class.com/cr220.htm/

Terms and conditions of use apply
Copyright © 2008 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Posted: June 2008

View comments

Hide
(web2)